Back to Agenda
Session 5 - Quality By Design “What is High-Quality Clinical Trial Data?”
Session Chair(s)
Keiichi Inaizumi, MSC
Clinical Study Innovation Lead, Clinical Project Management Group, Pfizer R&D Japan, Japan
Kazumasa Sugao
Head Administration Office, Japan Antibiotics Research Association, Japan
Miyoko Yamauchi
Head, Human Capital Development Group , CHUGAI PHARMACEUTICAL CO., LTD., Japan
Speaker(s)
Osamu Komiyama
Senior Manager, Statistical Research & Data Science, Pfizer R&D Japan G.K., Japan
Clinical Trial Data Overview
Keiko Funahashi
Japan Department of Clinical Research , Matsubara Mayflower Hospital, Japan
Clinical Study Data as Seen From a Facility’s Standpoint
Suzuko Oikawa, RPH
Director, Clinical Research, Bristol-Myers Squibb, Japan
Clinical Trial Data - Sponsor Perspective -
Eri Sekine
Executive Vice President Data Business, CMIC Co., Ltd, Japan
‘Selection and Concentration’ in Clinical Trial Data Collection
Rokuya Nochi
Head of Global Promotion Office, Business Strategy Center, EPS Group, Japan
Have an account?